Materials and Methods

Cell Culture
Human umbilical arterial endothelial cells (HUAEC) were isolated by collagenase treatment [1] and maintained in human endothelial cell specific medium (EBM-2, Lonza, Barcelona, Spain), supplemented with endothelial growth media (EGM-2, Lonza) and containing 10% fetal bovine serum (FBS; Biowest, Nuaillé, France). Cells were grown to confluence up to passage 1 to preserve endothelial features. Prior to every experiment, cells were incubated for 24 h in medium containing 2% FBS.
Flow Cytometry
Blood samples for flow cytometry studies were collected in BD Vacutainer® blood collection tubes containing 3.2% sodium citrate, or in BD Vacutainer® PST™ II tubes with lithium/heparin (17 IU/mL) as anticoagulant agents (both from BD Biosciences, San Jose, CA). All samples were run in a FACSVerse™ flow cytometer (BD Biosciences) and all flow cytometry data were analyzed with FlowJo® v10.0.7 software (FlowJo LLC, Ashland, OR).
To determine platelet activation, PAC-1 + platelets (detecting activated integrin αIIbβ3/GPIIb/IIIa) and the expression of P-selectin (CD62P) were measured in platelets by flow cytometry. Citrated blood samples (6.25 μL) were diluted 1:10 in glucose buffer (1 mg/mL glucose in phosphate buffered saline containing 0.35% bovine serum albumin; Sigma-Aldrich, Madrid, Spain). Samples were incubated in the dark for 30 min with a 5-carboxyfluorescein (CF)-Blue™-conjugated monoclonal antibody (mAb) against human CD41 (1.25 μL, clone HIP8, IgG1;
Immunostep, Salamanca, Spain) and a fluorescein isothiocyanate (FITC)-conjugated mouse mAb against the human integrin αIIbβ3/GPIIb/IIIa (2.5 μL, clone PAC-1, IgM; BD Biosciences), or with an allophycocyanin (APC)-conjugated mAb against human P-selectin (1.25 μL, clone HI62P, IgG1; Immunostep). The CD41 + population (platelets) was selected according to the gating strategy illustrated in Figure S1 and expressed as the percentage of positive platelets.
To determine the grade of leukocyte activation, the expression of CD11b was analyzed on circulating neutrophils, eosinophils and monocyte subsets, or CD69 expression on CD3 + T cells and lymphocyte subsets. Heparinized whole blood samples were incubated in the dark for 30 min with saturated amounts of a phycoerythrin (PE)-conjugated mAb against human integrin CD11b (clone CBRM1/5, IgG1; Biolegend, San Diego, CA) or a PE-conjugated mAb against human CD69 (clone FN50, IgG1; Immunostep). Fractalkine/CX3CL1 receptor (CX3CR1) expression was determined using a PE-conjugated rat mAb against human CX3CR1 (clone 2A9-1, IgG2B; Biolegend). In some experiments, heparinized blood samples were incubated with ethylenediaminetetraacetic acid (EDTA, 10 mM, for 15 min at 37ºC) to promote platelet dissociation as described [2] . This disaggregation was measured using the marker CD41 in circulating leukocyte subsets. To do this, heparinized whole blood or EDTA samples were incubated in the dark for 30 min with saturated amounts of a PE/Cy™7-conjugated mouse mAb against human CD41 (clone HIP8, IgG1; Biolegend) or a CF-Blue™-conjugated mAb against human CD41 (clone HIP8, IgG1; Immunostep).
Red blood cells were lysed using a commercial lysis buffer (BD FACS™ lysing solution 10× concentrate; BD Biosciences).
The expression of the different markers was determined on CD16 + (neutrophils, Figure   S2 ), CD16 -(eosinophils, Figure S2 ), CD14 + (monocytes, Table S2, Figure S3 ), CD3 + (T lymphocytes, Figure S4 ), CD8 + (cytotoxic lymphocytes, Figure S4 ), and CD4 + (T helper lymphocytes Figure S4 ).
Gating strategies are illustrated in Figures S2-S4.
Quantification of Soluble Inflammatory and Metabolic Markers
Heparinized human whole blood (17 IU heparin/mL) was collected and centrifuged to obtain the plasma, which was stored at -80ºC. The following cytokines, chemokines and adipokines were measured in plasma samples by enzyme-linked immunosorbent assay (ELISA; DuoSet® ELISA Development Systems, R&D Systems, Abingdon, UK) as previously described [3, 4] : human soluble interleukin (IL)-4, IL-6, IL-10, IL-12, IL-13, IL-25, IL-33, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, growth-regulated oncogene-α (GROα/CXCL1), platelet factor-4 (PF-4/CXCL4), IL-8/CXCL8, monocyte chemoattractant protein-1 (MCP-1/CCL2), regulated on activation normal T cell expressed and secreted chemokine (RANTES/CCL5), eotaxin-1/CCL11, eotaxin-2/CCL24, eotaxin-3/CCL26, fractalkine/CX3CL1 and soluble P-selectin (sP-selectin).
Results were expressed as pg or ng/mL of mediator in plasma.
Leukocyte-Endothelial Cell interactions Under Flow Conditions
Before starting each assay, whole blood was diluted 1:10 with Hank's balanced salt solution (HBSS; Lonza, Barcelona, Spain) without calcium or magnesium at 37ºC. Blood was In all experiments, leukocyte interactions were determined after 7 min at 0.5 dyn/cm 2 .
Cells interacting on the surface of the endothelium were visualized and recorded (×20 objective, ×10 eyepiece) using a phase-contrast microscopy (Axio Observer A1 Carl Zeiss microscope; Carl Zeiss, Thornwood, NY). For each determination, at least 5 fields were recorded for 10 s and then averaged. Finally, recorded images were saved on a computer for further analysis.
Immunofluorescence studies
To visualize adherent CX3CR1 and CCR2 expressing-platelet-leukocyte complexes, . Gating strategy for human monocyte detection in whole blood by flow cytometry. Monocytes were selected by CD14 labelling and morphology (medium SSC-A). For the detection of monocyte subpopulations, CD16 and CCR2 markers were used. Monocytes-platelets complexes were selected as CD14 + CD41 + populations in heparinized whole blood, and platelet-free monocytes were gated as CD14 + CD41 − from blood incubated with EDTA. Figure S4 . Gating strategy for human T lymphocyte detection in whole blood by flow cytometry. T lymphocytes were selected as a CD3 + population and with a low SSC-A. T helper (Th) lymphocytes were selected as the CD3 + CD4 + population. In heparinized blood, Th lymphocyte-platelet complexes were selected as the CD3 + CD4 + CD41 + population, whereas platelet-free Th lymphocytes were gated as CD3 + CD4 + CD41 − from blood incubated with EDTA. Cytotoxic lymphocytes were selected as CD3 + CD8 + . In heparinized blood, cytotoxic lymphocyte-platelet complexes were selected as the CD3 + CD8 + CD41 + population, whereas platelet free cytotoxic lymphocytes were selected as CD3 + CD8 + CD41 -from blood incubated with EDTA. Figure S5 . Flow cytometry detection and morphologic gating of human monocytes for the immunophenotype study of the different monocyte subsets. Classical monocytes (Mon1) were selected as CD14 + CD16 -population from whole blood. In order to study the monocyte immunophenotypic changes, eight gates were designed (S1-8) from CD14 + CD16 -to CD14 low CD16 + . 
